Study guide

9.3 Task-Based PPE Selection

PTCB Hazardous Drug Management Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

0.1 Exam Facts, Format & Eligibility 0.2 Content Outline, Scoring & Registration 0.3 USP <800> Big Picture & How to Use This Guide

2 USP <800> Program Administration

1.1 USP <800> Scope, Purpose & Enforcement 1.2 The NIOSH Hazardous Drug List (2024 Update) 1.3 Assessment of Risk 1.4 Designated Person, SOPs & the Hierarchy of Controls

3 Training, Compliance & Recordkeeping

2.1 Training Requirements & Medical Surveillance 2.2 Hazard Communication, SDS & OSHA Requirements 2.3 Recordkeeping & Professional Guidelines

4 Primary Engineering Controls

3.1 Containment Primary Engineering Controls (C-PEC): BSCs & CACIs 3.2 Closed System Transfer Devices (CSTDs) 3.3 Nonsterile Controls and the C-SCA Distinction

5 Secondary Engineering Controls & Facility Design

4.1 Containment Secondary Engineering Controls (C-SEC): Negative Pressure & Air Exchange 4.2 Facility Layout: Storage, Unpacking & Sink Placement 4.3 Certification, ISO Classes & Emergency Equipment

6 Facility Cleaning Procedures

5.1 The Four-Step Cleaning Process 5.2 Wipe Sampling & Action Levels 5.3 Hazardous Waste Disposal & RCRA

7 Spill Response & Cleaning PPE

6.1 Spill Kits & Spill Response Procedures 6.2 PPE During Cleaning: Glove Change Frequency & Disposal

8 Dispensing & the Compounding Interface

7.1 USP <795>/<797> Interface for Hazardous Drugs 7.2 High-Risk Oral Hazardous Drugs 7.3 Tablet Splitting & Crushing Restrictions

9 Counting, Packaging & Patient Counseling

8.1 Counting, Packaging & Dedicated Equipment 8.2 Patient Counseling & Unit-Dose Labeling

10 PPE: Gloves, Gowns & Task-Based Selection

9.1 ASTM D6978 Chemotherapy Gloves & Double Gloving 9.2 Chemo Gowns & Gown Change Frequency 9.3 Task-Based PPE Selection

11 Respiratory Protection, Eye Protection & PPE Sequencing

10.1 Respiratory & Eye/Face Protection 10.2 Donning & Doffing Sequence

12 Transport & Receiving

11.1 Receiving Hazardous Drug Shipments 11.2 Internal Transport & Storage 11.3 Damaged/Leaking Shipments & Chain of Custody

13 Exam Readiness & Final Review

12.1 Domain-by-Domain Quick Review 12.2 Common Exam Traps & Final Checklist

9.3 Task-Based PPE Selection

Key Takeaways Explain This Topic AI

An Assessment of Risk (AoR) can justify reduced PPE for specific low-manipulation tasks, but it can never eliminate the baseline minimum of at least one pair of ASTM D6978-tested chemo gloves for any HD-contact task.

Receiving, storage, and simple counting of intact final dosage forms may use single chemo gloving per facility SOP/AoR.

Sterile and nonsterile compounding always require double chemo gloves plus a chemo gown, regardless of what an AoR concludes for other tasks with the same drug.

Administration requires chemo gloves (often double per SOP) and a gown; a CSTD reduces but does not replace the PPE requirement when the dosage form allows one.

An AoR reduction is task-specific, not drug-wide — a reduced-PPE determination for receiving does not carry over to compounding the same drug.

Last updated: July 2026

Task-Based PPE Selection

Not every hazardous drug task carries the same PPE requirement, and treating every task identically — either over-protecting routine tasks or under-protecting higher-risk ones — is both a real-world safety issue and a heavily tested exam concept. USP <800> allows facilities to calibrate PPE to the task through a documented Assessment of Risk (AoR) , but that calibration only works in one direction: it can justify a reduced PPE tier for certain low-manipulation tasks, and it can never excuse skipping the baseline minimum of at least one pair of ASTM D6978-tested chemo gloves for any task that contacts an HD.

The Assessment of Risk (AoR)

An AoR is a facility's documented, drug-by-drug and task-by-task analysis of manipulation, dosage form, packaging integrity, frequency, and quantity handled. It allows alternative (typically reduced) containment strategies or PPE for specific low-risk tasks and drugs meeting defined criteria — but AoR-based reductions do not apply to sterile or nonsterile compounding, which always require full PPE regardless of what an AoR concludes for other tasks involving that same drug.

Matching PPE to the Task

Task Minimum PPE Notes

Receiving/unpacking At least single chemo gloves Escalate to a gown/full PPE if a shipment shows damage, leakage, or spillage

Storage/stock handling Single chemo gloves Intact, undamaged packaging in routine handling

Simple counting of intact final dosage forms (e.g., tablets into a dedicated tray) Single chemo gloves, per AoR/SOP Low-manipulation task with sealed/intact dosage units

Nonsterile compounding (C-SCA) Double chemo gloves + chemo gown Cannot be reduced via AoR

Sterile compounding (C-PEC: BSC/CACI) Double chemo gloves + chemo gown + additional sterile garb (hair/shoe covers, mask) Highest PPE tier; no AoR reduction

Administration to a patient Chemo gloves (often double per facility SOP) + gown A CSTD is used when a therapeutically appropriate dosage form allows one

Cleaning/deactivation/spill response Double chemo gloves + gown (+ respiratory/eye protection for spills) Same rigor as compounding

The pattern to notice: receiving and simple counting sit at the low end of the manipulation spectrum and may use single gloving; anything that involves compounding, manipulating, or generating aerosols or particles sits at the high end and always requires double gloving plus a gown, with sterile compounding adding garb on top. Administration sits in between — always gloved and gowned, with a CSTD reducing (not eliminating) the exposure pathway when the dosage form allows a closed connection.

Why "It's Just Counting" Is a Trap

A common exam distractor implies that counting a handful of intact oral tablets — say, tamoxifen or methotrexate — needs no special PPE because nothing is being opened, crushed, or reconstituted. This reasoning fails on two counts. First, oral HD tablets and capsules can carry surface drug residue from manufacturing or blister-pack handling even when intact, so bare-hand contact remains an exposure risk. Second, no special PPE is never a compliant answer for any HD-contact task — the true floor, even for the lowest-risk task on the table, is at least one pair of ASTM D6978-tested chemo gloves. An AoR can justify skipping the second glove or the gown for simple counting; it cannot justify skipping gloves altogether.

Why Compounding Never Gets an AoR Reduction

Sterile and nonsterile compounding involve direct manipulation of the drug itself — measuring, mixing, drawing up, or reconstituting — which is the highest-exposure-potential activity in the HD workflow. Because of that, compounding sits outside what an AoR can reduce: double gloves and a gown (plus sterile garb for sterile compounding) are required regardless of what the facility's risk assessment concludes for other tasks with that same drug. A technician cannot point to an AoR that reduced PPE for receiving a drug and use it to justify reduced PPE for compounding that same drug — the AoR's scope is task-specific, not drug-wide.

Exam Scenario

A technician receives a sealed, undamaged carton of injectable hazardous drug vials and, per the facility's Assessment of Risk, wears a single pair of ASTM D6978-tested chemo gloves to unpack and shelve them. Later that shift, the same technician is asked to compound one of those same vials into a sterile IV admixture inside a CACI. She reaches for a single pair of chemo gloves again, reasoning that the AoR already covered this drug. Is she correct?

No. The AoR that justified single gloving for receiving does not carry over to compounding. Compounding requires double chemo gloves and a chemo gown (plus sterile garb) regardless of any reduced-PPE determination made for a different, lower-manipulation task involving the same drug.

Key Takeaways

An Assessment of Risk (AoR) can justify reduced PPE for specific low-manipulation tasks, but it can never eliminate the baseline minimum of at least one pair of ASTM D6978-tested chemo gloves for any HD-contact task.

Receiving, storage, and simple counting of intact final dosage forms may use single chemo gloving per facility SOP/AoR.

Sterile and nonsterile compounding always require double chemo gloves plus a chemo gown, regardless of what an AoR concludes for other tasks with the same drug.

Administration requires chemo gloves (often double per SOP) and a gown; a CSTD reduces but does not replace the PPE requirement when the dosage form allows one.

An AoR reduction is task-specific, not drug-wide — a reduced-PPE determination for receiving does not carry over to compounding the same drug.